179 related articles for article (PubMed ID: 23380588)
1. Association between PCSK9 and LDLR gene polymorphisms with coronary heart disease: case-control study and meta-analysis.
Zhang L; Yuan F; Liu P; Fei L; Huang Y; Xu L; Hao L; Qiu X; Le Y; Yang X; Xu W; Huang X; Ye M; Zhou J; Lian J; Duan S
Clin Biochem; 2013 Jun; 46(9):727-32. PubMed ID: 23380588
[TBL] [Abstract][Full Text] [Related]
2. LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers.
Ochoa E; Iriondo M; Manzano C; Fullaondo A; Villar I; Ruiz-Irastorza G; Zubiaga AM; Estonba A
PLoS One; 2016; 11(1):e0146990. PubMed ID: 26820623
[TBL] [Abstract][Full Text] [Related]
3. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men.
Scartezini M; Hubbart C; Whittall RA; Cooper JA; Neil AH; Humphries SE
Clin Sci (Lond); 2007 Dec; 113(11):435-41. PubMed ID: 17550346
[TBL] [Abstract][Full Text] [Related]
4. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
[TBL] [Abstract][Full Text] [Related]
5. The associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis.
Cai G; Zhang B; Shi G; Weng W; Ma C; Song Y; Zhang J
Lipids Health Dis; 2015 Nov; 14():149. PubMed ID: 26576960
[TBL] [Abstract][Full Text] [Related]
6. Association of seven thrombotic pathway gene CpG-SNPs with coronary heart disease.
Ye H; Zhou A; Hong Q; Chen X; Xin Y; Tang L; Dai D; Ji H; Xu M; Wang DW; Duan S
Biomed Pharmacother; 2015 May; 72():98-102. PubMed ID: 26054681
[TBL] [Abstract][Full Text] [Related]
7. The Influence of OLR1 and PCSK9 Gene Polymorphisms on Ischemic Stroke: Evidence from a Meta-Analysis.
Au A; Griffiths LR; Cheng KK; Wee Kooi C; Irene L; Keat Wei L
Sci Rep; 2015 Dec; 5():18224. PubMed ID: 26666837
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of low density lipoprotein receptor (LDLR) rs2228671 polymorphism and coronary heart disease.
Ye H; Zhao Q; Huang Y; Wang L; Liu H; Wang C; Dai D; Xu L; Ye M; Duan S
Biomed Res Int; 2014; 2014():564940. PubMed ID: 24900971
[TBL] [Abstract][Full Text] [Related]
9. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.
Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M
Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy.
Bertolini S; Pisciotta L; Rabacchi C; Cefalù AB; Noto D; Fasano T; Signori A; Fresa R; Averna M; Calandra S
Atherosclerosis; 2013 Apr; 227(2):342-8. PubMed ID: 23375686
[TBL] [Abstract][Full Text] [Related]
11. LDL-c-linked SNPs are associated with LDL-c and myocardial infarction despite lipid-lowering therapy in patients with established vascular disease.
van de Woestijne AP; van der Graaf Y; de Bakker PI; Asselbergs FW; de Borst GJ; Algra A; Spiering W; Visseren FL;
Eur J Clin Invest; 2014 Feb; 44(2):184-91. PubMed ID: 24251769
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of familial hypercholesterolemia in Spain.
Palacios L; Grandoso L; Cuevas N; Olano-Martín E; Martinez A; Tejedor D; Stef M
Atherosclerosis; 2012 Mar; 221(1):137-42. PubMed ID: 22244043
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of the association of the rs2234693 and rs9340799 polymorphisms of estrogen receptor alpha gene with coronary heart disease risk in Chinese Han population.
Wei CD; Zheng HY; Wu W; Dai W; Tong YQ; Wang M; Li Y
Int J Med Sci; 2013; 10(4):457-66. PubMed ID: 23471591
[TBL] [Abstract][Full Text] [Related]
14. Characterization of LDLR rs5925 and PCSK9 rs505151 genetic variants frequencies in healthy subjects from northern Chile: Influence on plasma lipid levels.
Rojas C; Ramírez H; Salazar LA; Kalergis AM; Gálvez AS; Escobar-Vera J
J Clin Lab Anal; 2019 Nov; 33(9):e23001. PubMed ID: 31441123
[TBL] [Abstract][Full Text] [Related]
15. Association between Apo B, LDL-R and PCSK9 gene polymorphisms with coronary artery diseases in Egyptians.
Mahsoub N; Almenshawy A; Taki Eldin AM; Abdel Hay NM; Youssef AR; El-Farahaty RM; El-Sayed K; Osman AM; Elhennawy ES
Mol Biol Rep; 2024 Jun; 51(1):752. PubMed ID: 38874786
[TBL] [Abstract][Full Text] [Related]
16. Of PCSK9, cholesterol homeostasis and parasitic infections: possible survival benefits of loss-of-function PCSK9 genetic polymorphisms.
Mbikay M; Mayne J; Seidah NG; Chrétien M
Med Hypotheses; 2007; 69(5):1010-7. PubMed ID: 17502126
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms in promoter of angiotensin II type 1 receptor gene associated with essential hypertension and coronary heart disease in Chinese population.
Jin W; Liu Y; Sheng HH; Jin L; Shen YY; Hua Q; Lu L; Yu JD; Huang W
Acta Pharmacol Sin; 2003 Nov; 24(11):1083-8. PubMed ID: 14627489
[TBL] [Abstract][Full Text] [Related]
18. Interactions of several genetic polymorphisms and alcohol consumption on blood pressure levels.
Yin RX; Aung LH; Long XJ; Yan TT; Cao XL; Huang F; Wu JZ; Yang DZ; Lin WX; Pan SL
Biofactors; 2015; 41(5):339-51. PubMed ID: 26354227
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of PCSK9: its role in LDL metabolism.
Horton JD; Cohen JC; Hobbs HH
Trends Biochem Sci; 2007 Feb; 32(2):71-7. PubMed ID: 17215125
[TBL] [Abstract][Full Text] [Related]
20. PCSK9 gene mutations and low-density lipoprotein cholesterol.
Wu NQ; Li JJ
Clin Chim Acta; 2014 Apr; 431():148-53. PubMed ID: 24518357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
